about
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations.A Leishmania murine model to evaluate the immunomodulatory properties of Pythium insidiosum proteins.Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence.Immunotherapy for colorectal cancer: where are we heading?Modulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts.Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.Strategy to targeting the immune resistance and novel therapy in colorectal cancer.NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.Genotypic and phenotypic signatures to predict immune checkpoint blockade therapy response in patients with colorectal cancer.Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma.PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments.IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction.Viroimmunotherapy for Colorectal Cancer: Clinical Studies.Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation.
P2860
Q33574744-538AD4E6-3B9E-4D60-81D5-FBEE0BA164C7Q37735099-89676071-24F4-4575-9565-C582D47CF4E4Q38679229-2E99DB80-2E10-44F4-814A-5DF0E6E90771Q38961110-94EC9FD3-12CF-4379-8D41-AE78D25B48D9Q39218636-A7EC24A9-7F24-4FC8-89AD-B4A87A232DF9Q47097651-F6BFC5A3-6455-40EB-B6B7-AAFA52980F1FQ47571709-10A20AE7-D5EC-4D24-8549-15A305B25D8AQ48097366-4D7876AE-2100-4940-A390-8C8A74682FF6Q52320729-117A0D68-5A39-4958-81C8-C9D8910AC009Q52664398-6F11CF49-7B57-4D96-BA40-7B5C2C26F038Q52666692-5947F8B1-BC15-4235-8388-714F3B415239Q53834241-6FB73CC8-418B-4D6A-8B2F-A7E0C1BA049FQ54935837-75C1E4AA-F159-4926-8895-C5B51C8D3F22Q55081990-88E9BE89-7FAB-4A84-A4AD-F568ADA2AE60Q55085114-F774A32A-A74C-464B-A5E3-469CBAB319A1Q55316979-BA5CEEC9-3878-4649-885C-FF21A1490FCF
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The emerging role of immunotherapy in colorectal cancer
@ast
The emerging role of immunotherapy in colorectal cancer
@en
The emerging role of immunotherapy in colorectal cancer
@nl
type
label
The emerging role of immunotherapy in colorectal cancer
@ast
The emerging role of immunotherapy in colorectal cancer
@en
The emerging role of immunotherapy in colorectal cancer
@nl
prefLabel
The emerging role of immunotherapy in colorectal cancer
@ast
The emerging role of immunotherapy in colorectal cancer
@en
The emerging role of immunotherapy in colorectal cancer
@nl
P2860
P356
P1476
The emerging role of immunotherapy in colorectal cancer
@en
P2093
David Lynch
P2860
P356
10.21037/ATM.2016.08.29
P407
P577
2016-08-01T00:00:00Z